Abstract
Purpose of review: The purpose of this review is to summarize recent advances in the area of genetic polymorphisms in genes affecting immunosuppressive drug bioavailability with a specific emphasis on solid organ transplantation. Recent findings: Due to recent advances in molecular techniques, there has been an abundance of publications describing genetic variability in molecules relevant to pharmacogenetics. The initial studies in the field of transplantation demonstrate some associations between polymorphisms in these candidate genes with outcomes in organ transplantation.
Keywords: Transplantation, genetic polymorphisms, immunosuppressive drug, bioavailability
Current Pharmacogenomics
Title: Genomic Strategies in Transplantation “The Right Drug for the Right Patient”
Volume: 2 Issue: 2
Author(s): Bernd Schroppel
Affiliation:
Keywords: Transplantation, genetic polymorphisms, immunosuppressive drug, bioavailability
Abstract: Purpose of review: The purpose of this review is to summarize recent advances in the area of genetic polymorphisms in genes affecting immunosuppressive drug bioavailability with a specific emphasis on solid organ transplantation. Recent findings: Due to recent advances in molecular techniques, there has been an abundance of publications describing genetic variability in molecules relevant to pharmacogenetics. The initial studies in the field of transplantation demonstrate some associations between polymorphisms in these candidate genes with outcomes in organ transplantation.
Export Options
About this article
Cite this article as:
Schroppel Bernd, Genomic Strategies in Transplantation “The Right Drug for the Right Patient”, Current Pharmacogenomics 2004; 2 (2) . https://dx.doi.org/10.2174/1570160043377600
DOI https://dx.doi.org/10.2174/1570160043377600 |
Print ISSN 1570-1603 |
Publisher Name Bentham Science Publisher |
Online ISSN 1570-1603 |
Related Articles
-
Current State of ERG as Biomarker in Prostatic Adenocarcinoma
Current Cancer Drug Targets Telomeres, Telomerase and Malignant Transformation
Current Molecular Medicine Orthopedic Implant Used as Drug Delivery System: Clinical Situation and State of the Research
Current Drug Delivery Stathmin, Interacting with Nf-κB, Promotes Tumor Growth and Predicts Poor Prognosis of Pancreatic Cancer
Current Molecular Medicine Targeted Nanosystems to Prostate Cancer
Current Pharmaceutical Design Genetic Predisposition to Neonatal Tumors
Current Pediatric Reviews Lynch Syndrome: Awareness among Medical Students at a United States Medical School
Current Women`s Health Reviews Multi- and Inter-Disciplinary Science in Personalized Delivery of Stem Cells for Tissue Repair
Current Stem Cell Research & Therapy Adhesion Dependent Signalling in the Tumour Microenvironment: The Future of Drug Targetting
Current Pharmaceutical Design NOTCH Signaling as a Novel Cancer Therapeutic Target
Current Cancer Drug Targets Bioactive Albumin-Based Carriers for Tumour Chemotherapy
Current Cancer Drug Targets Noncovalent Binding to DNA: Still a Target in Developing Anticancer Agents
Current Medicinal Chemistry Colon Targeted Liposomal Systems (CTLS): Theranostic Potential
Current Molecular Medicine The Targets of Curcumin
Current Drug Targets STAT Signaling and Cell Function
Current Genomics Molecular Properties and Medical Applications of Peptide Nucleic Acids
Mini-Reviews in Medicinal Chemistry In Silico Designing and Screening of Antagonists against Cancer Drug Target XIAP
Current Cancer Drug Targets Peptidic Tumor Targeting Agents: The Road from Phage Display Peptide Selections to Clinical Applications
Current Pharmaceutical Design Therapeutic Potential of Plant Extracts and Phytochemicals Against Brain Ischemia-Reperfusion Injury: A Review
The Natural Products Journal Signal Transduction and Heavy Ion Radiation Therapy: Biological Mechanisms, Biological Quality Assurance, and New Multimodality Approach
Current Signal Transduction Therapy